| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11255-013-0598-5 |
| P698 | PubMed publication ID | 24265037 |
| P2093 | author name string | Yun Li | |
| Yong Liu | |||
| Jin Chen | |||
| Ning Tan | |||
| Shao-Hui Chen | |||
| Ji-Yan Chen | |||
| Yuan Hui Liu | |||
| Peng Ran | |||
| Piao Ye | |||
| Yi-Ting He | |||
| P2860 | cites work | TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy | Q22241926 |
| A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation | Q28285964 | ||
| 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34318814 | ||
| N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. | Q34542789 | ||
| Epidemiology and prognostic implications of contrast-induced nephropathy | Q34570528 | ||
| Preventing contrast nephropathy: what is the best strategy? A review of the literature | Q35722883 | ||
| Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines | Q37922124 | ||
| The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. | Q38071252 | ||
| Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events | Q39977385 | ||
| Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. | Q42170160 | ||
| Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease | Q42986096 | ||
| Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome | Q43149340 | ||
| Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty | Q43873696 | ||
| Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention | Q43993720 | ||
| Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes | Q44108434 | ||
| GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. | Q44314100 | ||
| Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge | Q44353713 | ||
| A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. | Q44928926 | ||
| Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study. | Q45393614 | ||
| Alprostadil plays a protective role in contrast-induced nephropathy in the elderly | Q47994820 | ||
| Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. | Q51485784 | ||
| Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species. | Q51743932 | ||
| Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. | Q54472097 | ||
| Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure | Q70971726 | ||
| Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) | Q76400658 | ||
| Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors | Q78016622 | ||
| The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention | Q83451225 | ||
| Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage dur | Q83999880 | ||
| High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score | Q84068991 | ||
| Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention | Q84165152 | ||
| C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention | Q84596813 | ||
| Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients | Q84903686 | ||
| High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention | Q84959810 | ||
| The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial | Q86568868 | ||
| P433 | issue | 2 | |
| P921 | main subject | myocardial infarction | Q12152 |
| acute kidney injury | Q424337 | ||
| P304 | page(s) | 417-426 | |
| P577 | publication date | 2013-11-22 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention | |
| P478 | volume | 46 |
| Q41147116 | Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function. |
| Q36009138 | Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function |
| Q34428322 | Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention |
| Q88156873 | Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention |
| Q48596144 | Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention? |
| Q64928431 | Negative association between free triiodothyronine level and contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention. |
| Q87360239 | Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention |
| Q92419589 | Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome |
| Q89635188 | Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort |
Search more.